| Predicted Trait | |
| Reported Trait | Thyroid cancer |
| Mapped Trait(s) | thyroid carcinoma (EFO_0002892) |
| Score Construction | |
| PGS Name | 1kgeur_gbmi_leaveUKBBout_ThC_pst_eff_a1_b0.5_phiauto |
| Development Method | |
| Name | PRS-CS-auto |
| Parameters | effective sample size and other defualt parameters |
| Variants | |
| Original Genome Build | GRCh37 |
| Number of Variants | 911,462 |
| Effect Weight Type | beta |
| PGS Source | |
| PGS Catalog Publication (PGP) ID | PGP000262 |
| Citation (link to publication) | Wang Y et al. Cell Genom (2023) |
| Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
|---|---|---|---|
| — | [
|
African unspecified | NR |
| — | [
|
Native American | NR |
| — | [
|
East Asian | 12 cohorts
|
| — | [
|
European | 10 cohorts
|
|
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
|---|---|---|---|---|---|---|---|---|
| PPM009298 | PSS007717| European Ancestry| 358,476 individuals |
PGP000262 | Wang Y et al. Cell Genom (2023) |
Reported Trait: Thyroid cancer | — | AUROC: 0.676 | Nagelkerke's R2 (covariates regressed out): 0.01366 | sex,age,age2,age*sex,age^2*sex, 20PCs | — |
|
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
|---|---|---|---|---|---|---|---|---|
| PSS007717 | — | — | [
|
— | European | — | UKB | — |